NCT05758662View on ClinicalTrials.gov

The Effect of Subclinical Leaflet Thrombosis and Prosthesis Type on Transcatheter Aortic Valve Degeneration (POPular PET TAVI)

RecruitingOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

November 16, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

November 30, 2025

Conditions
Aortic Valve Stenosis
Interventions
DIAGNOSTIC_TEST

18F-sodium fluoride Positron Emission Tomography (18F-NaF PET), Cardiac Computed Tomography (CT), Transthoracic Echocardiography (TTE)

Patients undergo a hybrid 18F-NaF-PET CT scan and TTE at five years after TAVI

Trial Locations (4)

Unknown

RECRUITING

Rigshospitalet, Copenhagen

RECRUITING

Amsterdam UMC, Amsterdam

NOT_YET_RECRUITING

University of Edinburgh, Edinburgh

3435 CM

RECRUITING

St. Antonius Hospital, Nieuwegein

Sponsors

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

St. Antonius Research Fund

UNKNOWN

collaborator

Medtronic

INDUSTRY

lead

St. Antonius Hospital

OTHER

NCT05758662 - The Effect of Subclinical Leaflet Thrombosis and Prosthesis Type on Transcatheter Aortic Valve Degeneration (POPular PET TAVI) | Biotech Hunter | Biotech Hunter